tradingkey.logo

ASP Isotopes Inc

ASPI
5.815USD
+0.600+11.51%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
542.99MMarktkapitalisierung
VerlustKGV TTM

ASP Isotopes Inc

5.815
+0.600+11.51%

mehr Informationen über ASP Isotopes Inc Unternehmen

ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.

ASP Isotopes Inc Informationen

BörsenkürzelASPI
Name des UnternehmensASP Isotopes Inc
IPO-datumNov 10, 2022
CEOAinscow (Robert)
Anzahl der mitarbeiter136
WertpapierartOrdinary Share
GeschäftsjahresendeNov 10
Addresse601 Pennsylvania Avenue Nw
StadtWASHINGTON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl20004
Telefon12027562245
Websitehttps://aspisotopes.com/
BörsenkürzelASPI
IPO-datumNov 10, 2022
CEOAinscow (Robert)

Führungskräfte von ASP Isotopes Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Paul Elliot Mann
Mr. Paul Elliot Mann
Executive Chairman of the Board
Executive Chairman of the Board
7.76M
-162153.00%
Mr. Robert Ainscow
Mr. Robert Ainscow
Interim Chief Executive Officer, Co-Founder, Chief Operating Officer
Interim Chief Executive Officer, Co-Founder, Chief Operating Officer
1.55M
-8438.00%
Dr. Duncan Moore, Ph.D.
Dr. Duncan Moore, Ph.D.
Independent Director
Independent Director
994.55K
--
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
772.25K
+36548.00%
Ms. Heather Kiessling
Ms. Heather Kiessling
Chief Financial Officer
Chief Financial Officer
732.50K
-80000.00%
Prof. Michael (Mike) Gorley, Ph.D.
Prof. Michael (Mike) Gorley, Ph.D.
Independent Director
Independent Director
117.91K
+36548.00%
Mr. Donald G. Ainscow
Mr. Donald G. Ainscow
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
100.00K
+100000.00%
Mr. Sipho Nkosinathi Maseko
Mr. Sipho Nkosinathi Maseko
Independent Director
Independent Director
22.42K
--
Dr. Hendrik Strydom, Ph.D.
Dr. Hendrik Strydom, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Robert Ryan
Mr. Robert Ryan
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Paul Elliot Mann
Mr. Paul Elliot Mann
Executive Chairman of the Board
Executive Chairman of the Board
7.76M
-162153.00%
Mr. Robert Ainscow
Mr. Robert Ainscow
Interim Chief Executive Officer, Co-Founder, Chief Operating Officer
Interim Chief Executive Officer, Co-Founder, Chief Operating Officer
1.55M
-8438.00%
Dr. Duncan Moore, Ph.D.
Dr. Duncan Moore, Ph.D.
Independent Director
Independent Director
994.55K
--
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
772.25K
+36548.00%
Ms. Heather Kiessling
Ms. Heather Kiessling
Chief Financial Officer
Chief Financial Officer
732.50K
-80000.00%
Prof. Michael (Mike) Gorley, Ph.D.
Prof. Michael (Mike) Gorley, Ph.D.
Independent Director
Independent Director
117.91K
+36548.00%

Umsatzaufteilung

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sat, Jan 31
Aktualisiert: Sat, Jan 31
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Mann (Paul Elliot)
6.20%
Encompass Capital Advisors, LLC
5.13%
The Vanguard Group, Inc.
5.10%
BlackRock Institutional Trust Company, N.A.
4.01%
AK Jensen Investment Management Ltd
3.96%
Andere
75.60%
Aktionäre
Aktionäre
Anteil
Mann (Paul Elliot)
6.20%
Encompass Capital Advisors, LLC
5.13%
The Vanguard Group, Inc.
5.10%
BlackRock Institutional Trust Company, N.A.
4.01%
AK Jensen Investment Management Ltd
3.96%
Andere
75.60%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
24.64%
Hedge Fund
12.05%
Investment Advisor/Hedge Fund
11.24%
Individual Investor
10.19%
Corporation
3.96%
Research Firm
2.65%
Family Office
0.26%
Bank and Trust
0.18%
Pension Fund
0.14%
Andere
34.68%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
254
55.02M
41.64%
+130.04K
2025Q3
254
54.89M
50.15%
+10.63M
2025Q2
214
44.26M
45.99%
+7.65M
2025Q1
172
35.12M
52.48%
-2.70M
2024Q4
150
32.56M
37.29%
+10.01M
2024Q3
115
22.54M
22.87%
+11.13M
2024Q2
83
8.83M
14.02%
+5.04M
2024Q1
42
3.79M
10.02%
-1.08M
2023Q4
23
1.67M
7.12%
+1.37M
2023Q3
16
308.07K
10.05%
-243.41K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Mann (Paul Elliot)
7.76M
7%
-162.15K
-2.05%
Dec 01, 2025
The Vanguard Group, Inc.
4.52M
4.08%
+1.24M
+37.89%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
5.02M
4.53%
+1.33M
+36.23%
Sep 30, 2025
AK Jensen Investment Management Ltd
4.96M
4.47%
+246.71K
+5.24%
Sep 30, 2025
Rovida Investment Management Ltd
3.20M
2.89%
+1.00M
+45.45%
Sep 30, 2025
AWM Investment Company, Inc.
2.96M
2.67%
-972.59K
-24.74%
Sep 30, 2025
Alyeska Investment Group, L.P.
2.82M
2.55%
-1.36M
-32.47%
Sep 30, 2025
Capital Research Global Investors
2.04M
1.84%
-824.50K
-28.75%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Range Nuclear Renaissance Index ETF
2.07%
Invesco Dorsey Wright Basic Materials Momentum ETF
1.84%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.23%
iShares Micro-Cap ETF
0.15%
Vanguard US Momentum Factor ETF
0.14%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
iShares Russell 2000 Growth ETF
0.04%
Schwab U.S. Small-Cap ETF
0.03%
Global X Russell 2000 ETF
0.03%
Proshares Ultra Russell 2000
0.03%
Mehr Anzeigen
Range Nuclear Renaissance Index ETF
Anteil2.07%
Invesco Dorsey Wright Basic Materials Momentum ETF
Anteil1.84%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Anteil0.23%
iShares Micro-Cap ETF
Anteil0.15%
Vanguard US Momentum Factor ETF
Anteil0.14%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.06%
iShares Russell 2000 Growth ETF
Anteil0.04%
Schwab U.S. Small-Cap ETF
Anteil0.03%
Global X Russell 2000 ETF
Anteil0.03%
Proshares Ultra Russell 2000
Anteil0.03%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI